Viela Bio Inc

NASDAQ:VIE   3:59:41 PM EDT
36.16
-0.49 (-1.34%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.98B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5.55 Million
Adjusted EPS-$0.70
See more estimates
10-Day MA$37.09
50-Day MA$37.16
200-Day MA$38.48
See more pivots

Viela Bio, Inc. Stock, NASDAQ:VIE

1 MEDIMMUNE WAY, GAITHERSBURG, MD 20878
United States of America
Phone: 240-780-6356
Number of Employees:

Description

Clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, which we collectively refer to as autoimmune diseases. Our approach seeks to redefine the treatment of autoimmune diseases by focusing on critical biological pathways shared across multiple indications. We believe that this approach, which targets the underlying molecular pathogenesis of the disease, allows us to develop more precise therapies, identify patients more likely to respond to treatment and pursue multiple indications for each of our product candidates.